Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30014379
Basic Information
VIS ID
TVIS30014379
Fusion event
HIV-GRB2 integration
Validated
Yes
Detection method
invPCR
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2007
PubMed ID
17262715
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr17
Cytoband
q25.1
Reference genome
GRCh37/hg19
Start
73396708/75400627 (Hg38)
End
73396708/75400627 (Hg38)
Orient
+
Location type
Intronic
Target gene
GRB2
miRNAs that regulate target gene
hsa-mir-433-3p
;
hsa-mir-378a-3p
;
hsa-mir-124-3p
;
hsa-mir-34a-5p
;
hsa-mir-7-5p
;
hsa-mir-93-5p
;
hsa-mir-16-5p
;
hsa-mir-92b-3p
;
hsa-mir-100-5p
;
hsa-mir-376c-3p
;
hsa-mir-27a-3p
;
hsa-mir-200a-3p
;
hsa-mir-541-5p
;
hsa-mir-6834-5p
;
hsa-mir-3915
;
hsa-mir-5196-5p
;
hsa-mir-6787-5p
;
hsa-mir-4747-5p
;
hsa-mir-663a
;
hsa-mir-1908-5p
;
hsa-mir-1255b-5p
;
hsa-mir-1255a
;
hsa-mir-6077
;
hsa-mir-4749-5p
;
hsa-mir-4706
;
hsa-mir-6133
;
hsa-mir-6130
;
hsa-mir-6129
;
hsa-mir-6127
;
hsa-mir-4510
;
hsa-mir-6875-5p
;
hsa-mir-4419a
;
hsa-mir-3126-5p
;
hsa-mir-3928-3p
;
hsa-mir-9500
;
hsa-mir-6165
;
hsa-mir-5586-3p
;
hsa-mir-3934-5p
;
hsa-mir-7853-5p
;
hsa-mir-105-5p
;
hsa-mir-522-3p
;
hsa-mir-224-3p
;
hsa-mir-2054
;
hsa-mir-6739-5p
;
hsa-mir-6733-5p
;
hsa-mir-3153
;
hsa-mir-6081
;
hsa-mir-6783-5p
;
hsa-mir-4779
;
hsa-mir-4519
;
hsa-mir-6838-5p
;
hsa-mir-497-5p
;
hsa-mir-424-5p
;
hsa-mir-195-5p
;
hsa-mir-15b-5p
;
hsa-mir-15a-5p
;
hsa-mir-6891-5p
;
hsa-mir-3173-3p
;
hsa-mir-583
;
hsa-mir-4282
;
hsa-mir-548x-3p
;
hsa-mir-548j-3p
;
hsa-mir-548aq-3p
;
hsa-mir-548am-3p
;
hsa-mir-548aj-3p
;
hsa-mir-548ah-3p
;
hsa-mir-548ae-3p
;
hsa-mir-548z
;
hsa-mir-548h-3p
;
hsa-mir-548d-3p
;
hsa-mir-548bb-3p
;
hsa-mir-548ac
;
hsa-mir-329-3p
;
hsa-mir-411-5p
;
hsa-mir-96-3p
;
hsa-mir-1281
;
hsa-mir-18a-3p
;
hsa-mir-1913
;
hsa-mir-221-5p
;
hsa-mir-22-3p
;
hsa-mir-3120-3p
;
hsa-mir-3155a
;
hsa-mir-3155b
;
hsa-mir-3194-3p
;
hsa-mir-324-3p
;
hsa-mir-4438
;
hsa-mir-4632-3p
;
hsa-mir-484
;
hsa-mir-5197-3p
;
hsa-mir-545-3p
;
hsa-mir-558
;
hsa-mir-660-3p
;
hsa-mir-6791-3p
;
hsa-mir-6829-3p
;
hsa-mir-760
;
hsa-mir-8073
Nearest miRNA
hsa-mir-10226/Upstream/651928; hsa-mir-1250/Downstream/5442;
Nearest TSS
ENST00000595228/Upstream/6504;
ENST00000581834/Downstream/4859;
Nearest CpG islands
None/Target,
chr17-CpG: 26/Upstream/110854
,
chr17-CpG: 77/Downstream/4509
Upstream sequence
gcagtggtgtgatctcatctcactgtaacctccacctcctgcgttcaagcgattctccttgcctcagcctcccaagtagctgggattccaggcgtgtcac
Downstream sequence
caccacctaatttttgaattttctttttttgtgtgtttgtgtgtgtttttaatgtttgtattttcaaataaagacgaggtttcaccatgttggccaggct
Reference
Ikeda, T., et al. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J Infect Dis,2007, 195(5): 716-725.
Sample Information
×
Sample type
PBMC
Gender
Female
CpG Island Information
×
Download
Curate